Cell of origin in radiation-induced premalignant thymocytes with differentiation capability in mice conditionally losing one Bcl11b allele

Cancer Science

Volumn 104, Issue 8, 2013, Pages 1009-1016

  Go, Rieka ^a   Hirose, Satoshi ^a   Katsuragi, Yoshinori ^a   Obata, Miki ^a   Abe, Manabu ^b   Mishima, Yukio ^a   Sakimura, Kenji ^b   Kominami, Ryo ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CRE RECOMBINASE; PROTEIN BCL 11B; PROTEIN KINASE LCK; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL EXPANSION; CELL PROLIFERATION; CELL SUBPOPULATION; CLONAL VARIATION; CONTROLLED STUDY; DEVELOPMENTAL STAGE; GAMMA IRRADIATION; GENE DELETION; GENE EXPRESSION; GENE LOCUS; GENE REARRANGEMENT; GENE SILENCING; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYMOCYTE; THYMUS;

EID: 84881105972     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12193     Document Type: Article

References (30)

1. Kaplan HS, Carnes WH, Brown MB, et al. Indirect induction of lymphomas in irradiated mice. I. Tumor incidence and morphology in mice bearing nonirradiated thymic grafts. Cancer Res 1956; 16: 422-5.
2. Muto M, Kubo E, Sado T. Development of prelymphoma cells committed to thymic lymphomas during radiation-induced thymic lymphomagenesis in B10 mice. Cancer Res 1987; 47: 3469-72.
3. Sado T, Kamisaku H, Kubo E. Bone marrow-thymus interactions during thymic lymphomagenesis induced by fractionated radiation exposure in B10 mice: analysis using bone marrow transplantation between Thy 1 congenic mice. J Radiat Res 1991; 32: 168-80.
4. Kominami R, Niwa O. Radiation carcinogenesis in mouse thymic lymphomas. Cancer Sci 2006; 97: 575-81.
5. Armstrong SA, Look AT. Molecular genetics of acute lymphoblastic leukemia. J Clin Oncol 2005; 23: 6306-15.
6. Paganin M, Ferrando A. Molecular pathogenesis and targeted therapies for NOTCH1-induced T-cell acute lymphoblastic leukemia. Blood Rev 2011; 25: 83-90.
7. Kominami R. Role of the transcription factor Bcl11b in development and lymphomagenesis. Proc Jpn Acad Ser B Phys Biol Sci 2012; 88: 72-87.
8. Wakabayashi Y, Inoue J, Takahashi Y, et al. Homozygous deletions and point mutations of the Rit1/Bcl11b gene in gamma-ray induced mouse thymic lymphomas. Biochem Biophys Res Commun 2003; 301: 598-603.
9. Wakabayashi Y, Watanabe H, Inoue J, et al. Bcl11b is required for differentiation and survival of αβT lymphocytes. Nat Imnunol 2003; 4: 533-9.
10. Keersmaecker K, Real PJ, Gatta GD, et al. The TLX1 oncogene drives aneuploidy in T cell transformation. Nat Med 2010; 16: 1321-7.
11. Kamimura K, Ohi H, Kubota T, et al. Haploinsufficiency of Bcl11b for suppression of lymphomagenesis and thymocyte development. Biochem Biophys Res Commun 2007; 355: 538-42.
12. Gutierrez A, Kentsis A, Sanda T, et al. The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia. Blood 2011; 118: 4169-73.
13. Ohi H, Mishima Y, Kamimura K, Maruyama M, Sasai K, Kominami R. Multi-step lymphomagenesis deduced from DNA changes in thymic lymphomas and atrophic thymuses at various times after γ-irradiation. Oncogene 2007; 26: 5280-9.
14. Go R, Hirose S, Morita S, et al. Bcl11b heterozygosity promotes clonal expansion and differentiation arrest of thymocytes in gamma-irradiated mice. Cancer Sci 2010; 101: 1347-53.
15. McCormack MP, Young LF, Vasudevan S, et al. The Lmo2 Oncogene Initiates Leukemia in Mice by Inducing Thymocyte Self-Renewal. Science 2010; 327: 879-83.
16. Li GC, Ouyang H, Li X, et al. Ku70: a candidate tumor suppressor gene for murine T cell lymphoma. Mol Cell 1998; 2: 1-8.
17. Onoyama I, Tsunematsu R, Matsumoto A, et al. Conditional inactivation of Fbxw7 impairs cell-cycle exit during T cell differentiation and results in lymphomatogenesis. J Exp Med 2007; 204: 2875-88.
18. Xue L, Nolla H, Suzuki A, et al. Normal development is an integral part of tumorigenesis in T cell-specific PTEN-deficient mice. Proc Natl Acad Sci U S A 2008; 105: 2022-7.
19. Guo W, Schubbert S, Chen JY, et al. Suppression of leukemia development caused by PTEN loss. Proc Natl Acad Sci U S A 2011; 108: 1409-14.
20. Takahama Y, Ohishi K, Tokoro Y, et al. Functional competence of T cells in the absence of glycosylphosphatidylinositol-anchoredproteins caused by T cell-specific disruption of the Pig-a gene. Eur J Immunol 1998; 28: 2159-66.
21. Lee PP, Fitzpatrick DR, Beard C, et al. A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity 2001; 15: 763-74.
22. Kawamoto H, Ohmura K, Fujimoto S, et al. Extensive proliferation of T cell lineage-restricted progenitors in the thymus: an essential process for clonal expression of diverse T cell receptor beta chains. Eur J Immunol 2003; 33: 606-15.
23. Hu T, Simmons A, Yuan J, et al. The transcription factor c-Myb primes CD4+CD8+ immature thymocytes for selection into the iNKT lineage. Nat Immunol 2010; 11: 435-41.
24. Fischer A, Malissen B. Natural and engineered disorders of lymphocyte development. Science 1998; 280: 237-43.
25. Siegler R, Harrwll W, Rich MA. Pathogenesis of radiation-induced thymic lymphoma in mice. J Natl Cancer Inst 1966; 37: 105-21.
26. Go R, Takizawa K, Hirose S, et al. Impairment in differentiation and cell cycle of thymocytes by loss of a Bcl11b tumor suppressor allele that contributes to leukemogenesis. Leuk Res 2012; 36: 1035-40.
27. Bartkova J, Horejsi Z, Koed K, et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 2005; 434: 864-70.
28. Gorgoulis VG, Vassiliou LV, Karakaidos P, et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 2005; 434: 907-13.
29. Obata M, Kominami R, Mishima Y. BCL11B tumor suppressor inhibits HDM2 expression in a p53-dependent manner. Cell Signal 2012; 24: 1047-52.
30. Berquam-Vrieze KE, Nannapaneni K, Brett BT, et al. Cell of origin strongly influences genetic selection in a mouse model of T-ALL. Blood 2011; 118: 4646-56.